Stefano Bazzocchi
Plus aucun poste en cours
Profil
Mr. Stefano Bazzocchi is Vice President-Finance at Caprion Proteomics, Inc.
Mr. Bazzocchi was previously employed as Chief Financial Officer by Mitec Telecom, Inc. and Controller & Vice President-Finance by Nexia Biotechnologies, Inc.
He received his undergraduate degree from Concordia University.
Anciens postes connus de Stefano Bazzocchi
| Sociétés | Poste | Fin |
|---|---|---|
| MITEC TECHNOLOGIES INC | Directeur Financier/CFO | - |
Nexia Biotechnologies, Inc.
 Nexia Biotechnologies, Inc. BiotechnologyHealth Technology Nexia Biotechnologies produces therapeutic proteins and other biomaterials for the treatment of serious disease | Directeur Financier/CFO | - |
CellCarta Biosciences, Inc.
 CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada. | Directeur Financier/CFO | - |
Formation de Stefano Bazzocchi
| Concordia University | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Mitec Technologies, Inc.
 Mitec Technologies, Inc. Computer CommunicationsElectronic Technology Mitec Technologies, Inc. was engaged in manufacturing wireless telecommunications equipment. The company was founded on May 1, 1996 and was headquartered in Toronto, Canada. | Electronic Technology |
CellCarta Biosciences, Inc.
CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada. | Commercial Services |
Nexia Biotechnologies, Inc.
Nexia Biotechnologies, Inc. BiotechnologyHealth Technology Nexia Biotechnologies produces therapeutic proteins and other biomaterials for the treatment of serious disease | Health Technology |
